From mechanism to clinical: research evolution and hotspot analysis of CD276/B7-H3 in cancer immunotherapy.
Saved in:
| Title: | From mechanism to clinical: research evolution and hotspot analysis of CD276/B7-H3 in cancer immunotherapy. |
|---|---|
| Authors: | Zhai C; Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.; Precision Oncology Medicine Center, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China., Ye J; Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.; Precision Oncology Medicine Center, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China., Li X; Biobank Center, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China., Liu J; Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.; Precision Oncology Medicine Center, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China., Zhou X; Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.; Precision Oncology Medicine Center, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China., Wang Z; Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.; Precision Oncology Medicine Center, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China., Zhang X; Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.; Precision Oncology Medicine Center, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.; Department of Anesthesiology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China., Zeng W; Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.; Precision Oncology Medicine Center, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.; Department of Anesthesiology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China., Luo H; Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.; Precision Oncology Medicine Center, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China., Chen L; Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.; Precision Oncology Medicine Center, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.; Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.; Medical Center for Cardiovascular Diseases, Neurological Diseases and Tumors of Jiangxi Province, The Second Affiliated Hospital of Nanchang University, Nanchang, China., Zhou F; Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.; Precision Oncology Medicine Center, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Apr 01; Vol. 17, pp. 1751400. Date of Electronic Publication: 2026 Apr 01 (Print Publication: 2026). |
| Publication Type: | Journal Article; Review; Systematic Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1751400 |
